Serving as EVP - Selected to lead all capital market interactions, investor relations campaigns, corporate and business strategy. Led all investor relations and business development activities of an R&D company focused on commercializing a proprietary, miniaturized mm-wave traveling wave tube platform technology for use in C4ISR applications.• Led all third-party capital investments, assisting counsel with document prep and due diligence requests. Negotiated and executed $2M term sheet and investment (2022) with $2B Virginia Based Family Office as well as negotiated and executed USD $36M, Series B Term Sheet from UK family office (2024) (inclusive of JV and License Agreement) • Led the development and creation of all presentations used in investor updates/meetings, analyst interactions, board meetings, non-deal roadshows and industry conferences • Assisted Chairman, CEO, CFO, and corporate counsel in the consolidation and restructuring of $6M in legacy debt and the preparation of quarterly financial reports• Led Execution of Strategic Partnership with leading publicly traded specialized SATCOM manufacturer and government R&D company leading to company winning a $14M OTA for nonlethal active denial system utilizing companies mm-wave technology. • Led the execution of “Proof of Concept” R&D initiative with Global Fortune 100 Communications Company. • Co-wrote and created twelve RFP’s SBIR’s OTA’s CREDA’s, US Government R&D program documents

Selected to lead all capital market interactions, investor relations campaigns, corporate and business strategy, marketing campaigns, R&D Collaborations and JV Studies for air and surface disinfection Company with 75 employees that completed 5 acquisitions of assets with USD $22M in combined revenue with distribution in 52 countries globally• Led and assisted the CEO and CFO post IPO with third party capital investments. Assisted counsel with document review and completing five rounds of US capital raises totaling $40M to include the creation of all presentations used in interactions with analyst, board meetings, both non and deal roadshows, conferences, and investor meetings• Led Global Strategic Partnerships - 360 Biopharma - $3M Master Airocide Distributor partnership. Introduced KOL’s throughout the continent of Africa. • Co-Led the Negotiation all other international Joint Venture initiatives • Identified and Led discussions resulting in execution of global contract OEM (Canon Virginia) to bring all manufacturing on shore and reduce supply chain, logistics risks while lowering production costs and reduction of manufacturing execution risk • Assisted the CFO with all MD&A creation for all SEC reporting, quarterly conference call talking points and assisted in the review of detailed financial analysis and models for operating subsidiaries both to determine CAPEX & OPEX

Selected to lead all non-R&D day-to-day operations as company transitioned focus from R&D to pre-market launch of disruptive medical device (CSS) used to detect arterial stenosis in carotid arteries. Led all global capital market, public and invester relation activities to accomplish company mandate of addressing inefficiencies in the detection of stenosis in carotid arteries (time to treatment, and cost to system) leading to improved leadership position while potentially improving patient outcomes dramatically reduce healthcare costs. • Led all Capital Markets fundraising, third party capital investments, negotiating term sheets, assisting counsel with document review completing eight rounds of cross boarder capital raises totaling CAD $28M.• Built consensus with majority stakeholders on all matters requiring participation and vote.• Led and promoted strategic retstructuring plan to new, existing equity holders and institutional funds via road shows and conference calls to gain approval by all stakeholders, regulators and leading to additional funding and exposure. • Led Executive Team, US & Canadian Counsel listing application on US Capital Markets including the preparation of all MD&A and other summary sections for all Regulatory filings. • Co-Led the Negotiation of all international Joint Venture initiatives. • Led & Developed all corporate communications, business plans, fact sheets and presentations used in analyst, board meetings, both non and deal roadshows and investor meetings. • Led all Investor Relations drafting, editing and disseminating REG FD compliant press releases to company stakeholders and public. Led all IR/PR campaigns via International and Domestic targeted Non-Deal Road Shows and Industry Conferences. • Identified and recruited Global industry thought leaders augmenting executive teams and board of directors to effectively address operational issues, implement financial controls and minimize execution risk.

Selected to lead all non-exploration operations of world-class lithium asset in Salar De Maricunga, Chile. Led the business development activities to identify technologies to accomplish company mandate of addressing inefficiencies in lithium production process (time to market, large land foot print & yield loss) leading to improved leadership position while increasing competitive advantage over peer group. •Involved with all fundraising, third party capital investments, negotiating term sheets, assisting counsel with document review including POSCO’s US18M investment. •Built consensus with majority stakeholders on all matters requiring participation and vote.•Led & promoted strategic plan to existing equity holders & institutional funds via road shows & conference calls to gain additional funding & exposure. •Led listing application on TSE including the preparation of all MD&A & other summary sections. •Negotiated R&D MOU to explore & commercialize proprietary evaporative technology for use in lithium production, significantly lowering CAPEX, improve environmental impact with smaller land foot-print, capturing & purifying water in lithium exploring process. •Team executed flawless two-stage US$18M development program on time & budget. When compared to peer group, company achieved positive results by incorporating parallel exploration programs saving time (one-year vs. 2-3 years) & capital ($18M vs. $25-40M). SIGNUMBox ranking of 4th best undeveloped lithium.•Led document management & database access to facilitate receipt of due-diligence documents to interested parties. Developed all business plans, fact sheets and presentations used in analyst, board and investor meetings. •Led drafting of all MD&A and other summary sections in all SEC Filings.•Led all IR drafting, editing & disseminating REG FD compliant press to company stakeholders & public. Led all IR/PR campaigns via International & Domestic targeted Non-Deal Road Shows and Industry Conferences.

Collaborating with start-up and early-stage ventures in multiple industries while serving in interim executive or consultant capacity, provided counsel to 36 domestic and international companies across multiple industries preparing them for the capital markets creating self-sustaining, compelling businesses in high growth industries. • Leveraged public/private company experience with proven leadership and unique skill sets resulting in improved operational efficiencies and readiness of engaged companies• Identified and recruited industry thought leaders augmenting executive teams and board of directors to effectively address operational issues, implement financial controls and minimize execution risk of engaged companies • Transformed culture of development stage to fully operational company through integration of commercial and operations teams, focusing on key drivers of business, and minimizing costs for engaged companies• Created business plans and presentations, set road shows assisting in capital raises for engaged companies• Led business development, strategic partnership activities that augmented competitive advantage and improved leadership position, operation economics and impacting future revenue growth of engaged companies• Led all investor relation activities by timely drafting and disseminating compliant press releases and building investor awareness and confidence for engaged companies

Cultivated domestic and international client base of over 300 accredited investors, providing wide variety of sophisticated, financial products, matching investment objectives. • Managed in excess of US$150M in assets. Honored as Top Producer in 9 out of 12 years of active production.• Identified and screened companies seeking capital, reviewing business plans, management and board strength, capital structure, valuation and competition to assess whether project met firms banking criteria.• Supervised, recruited, trained and mentored 100 junior account executives in all aspects of firms financial products, lead generation, client cultivation, retention and, sales strategies. Co-led national collegiate recruiting campaigns conducting interviews to determine qualifications, cultural and behavioral fit within firm.